ctrl K

Tevogen Bio Inc. (TVGN)

NASDAQ: TVGN · Real-Time Price · USD

0.98

-0.05 (-4.85%)

At close: May 01, 2025, 3:59 PM

0.97

-0.51%

Pre-market: May 02, 2025, 09:13 AM EDT

Tevogen Bio Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a
Operating Income	-53.56M	-8.84K	-13.72M	-4.62M
Interest Income	n/a	n/a	n/a	n/a
Pretax Income	-13.73M	-67.33K	4.41M	-15.6M
Net Income	-13.73M	-67.33K	4.41M	-15.6M
Selling & General & Admin	22.53M	2.27M	953.08K	1.66M
Research & Development	31.03M	n/a	5.77M	2.96M
Other Expenses	n/a	n/a	-7.38M	-10.38M
Operating Expenses	53.56M	2.27M	953.08K	4.62M
Interest Expense	n/a	256.03K	n/a	598.5K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	2.27M	953.08K	4.62M
Income Tax Expense	n/a	n/a	-230.82K	-9.78M
Shares Outstanding (Basic)	146.67M	165.42M	120M	120M
Shares Outstanding (Diluted)	146.67M	165.42M	120M	120M
EPS (Basic)	-0.09	-0.00	0.04	-0.13
EPS (Diluted)	-0.09	-0.00	0.04	-0.13
EBITDA	-53.56M	188.71K	-953.08K	-28.75K
EBIT	-13.91M	188.71K	-13.72K	-28.75K
Depreciation & Amortization	-39.65M	197.55K	230.82K	9.38K